|
Confirmed Speakers
Phyllis Whiteley, Executive-in-Residence, Moha Davidow Ventures
Yi-Wei Tang, Associate Professor, Vanderbilt University Medical Centre
Steven Bodovitz, Principal, Bio Perspectives
Huimin Kong, President and COO, BioHelix Corporation
Stephen Jackson, Field Application Scientist, Nanostrings Technologies
Mike G. Makrigiorgos, Associate Professor, Dana Farber Cancer Institute
Emmanel Monnet, Head of Biomarkers Merck Serono
Danxin Wang, Research Scientist, The Ohio State University
Yaron Kinar, research Scientist, Compugen
Bruce Schiamber, Research Analyst, Lux Research
Norman C. Nelson, Director of BioChemistry, Gen-Probe
Galina Fomovska, Senior Principal Scientist, Pall Life Sciences
Vladimir Tolstikoc, Director, Core Facility, University College Davis
Walter Gall, Programme Maanger, Diagnostics Development, Metabolon
Enal Razvi, Biotechnology Analyst, Select Biosciences |